product image
Toujeo to treat Type 1 Diabetes; TauRx for Alzheimer’s patients

Jun 29, 2020

Sanofi’s Toujeo has received FDA recommendation for its expanded use in Type 1 Diabetes. Toujeo is an insulin glargine injection to control the highs and lows of blood su...

Read More
product image
Novel treatment approval promises a better future for Sickle cell disease patients

Nov 27, 2019

Sickle cell disease is a haematological, genetic disorder that affects millions of people worldwide. According to the NIH, “Sickle cell disease is the most common inherit...

Read More
product image
How Gene therapy is changing the Beta-thalassemia Treatment outlook?

Jun 29, 2020

Beta thalassemia, globally affects almost 288,000 people, with an incidence of 60,000 cases every year. A rare monogenic genetic disease, beta-thalassemia is caused by more...

Read More
product image
The long journey of Biosimilars: Is it an emerging opportunity?

Feb 5, 2020

Biologics are not new drugs, their use as a medicine has been around for over a century. The first use of Biologic drug dates back to the year 1796 when the vaccine to trea...

Read More
product image
Antimicrobial resistance crisis: A global need for antibiotic awareness

Jun 26, 2020

Antimicrobial resistance (AMR) is a global threat. As per the UN estimates, the global trends reveal that each year 7,00,000 people die due to drug-resistance. Moreover, ar...

Read More
product image
Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

Apr 16, 2020

Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases. The companies will be focusing to ...

Read More
product image
Is Air Pollution a driver in COPD Treatment Market?

Jun 26, 2020

Levels of air pollution have risen dramatically over the past years due to increasing outdoor human activities such as industrialization, urbanization and indoor activities...

Read More
product image
FDA declines the approval of Lipocine’s testosterone drug; Novartis Sandoz to buy Aspen Pharmacare Japanese Unit

Feb 14, 2020

The US FDA for the third time has refused to give approval to Lipocine’s oral testosterone drug, Tlando. The drug is an oral testosterone replacement therapy in clinical ...

Read More
product image
Evotec, Vifor Pharma collaborates to cure kidney diseases; AZ takes major steps to advance pharma and medicine R&D in China; Amneal licenses-in a Myasthenia Gravis drug from Kashiv BioSciences

Feb 14, 2020

Switzerland-based Vifor Pharma and Germany-based Evotech AG have collaborated for the development and discovery of new treatments for kidney diseases. The launch of a new 5...

Read More
product image
AstraZeneca tops the first Pharma Invention Index; Amgen to buy 20.5% stake in a Chinese pharmaceutical, BeiGene; Ascentage, Henlius collaborates to develop a Combination therapy

Feb 14, 2020

Amgen has announced to purchase 20.5% of the stake in Chinese-American drug company BeiGene. As per the deal signed, Amgen will develop and commercialize around two dozen o...

Read More
product image
The growing size of Sanfilippo syndrome Market: Drivers and Barriers

Nov 4, 2019

Sanfilippo syndrome, also known as mucopolysaccharidosis type III (MPS III), is a rare genetic disorder that affects the Central Nervous system. It is a result of a mutatio...

Read More
product image
AZ sells EU rights for Schizophrenia to Cheplapharm; Astellas, Pandion unite to extract the potential of immunomodulation; Pear therapeutics on a journey to develop digital GI treatments with Ironwood

Jun 29, 2020

AstraZeneca has announced the licensing-out of two of its drugs Seroquel and Seroquel XR in Europe and Russia to Cheplapharm Arzneimittel GmbH. According to the deal signed...

Read More
product image
Geographic Atrophy Treatment Market: Novel Therapies to Enter the Market

Jul 20, 2020

Geographic atrophy (GA) is a severe, progressive, irreversible vision loss in old age people. The loss in the vision is due to the damage in a small portion of the retina a...

Read More
product image
AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development

Apr 17, 2020

AstraZeneca recently has announced the results of the clinical trials POSEIDON which included the study of a combination of drugs Imfinzi (durvalumab) and tremelimumab with...

Read More
product image
Rapt Therapeutics files IPO; Novartis stakes $80M for NASH

Jun 29, 2020

Rapt Therapeutics files for IPO at $75M Rapt Therapeutics, based in the US, filed to raise to $75 million in its IPO. This had come after five months when the company had r...

Read More